Vermont currently has no law requiring insurers or Vermont Medicaid to cover fertility diagnosis, treatment, or IVF. Two bills that would have created a broad mandate — H.55 and H.302 — both died in committee in the 2025-2026 biennium without a floor vote.
How to appeal a denial
Internal appeal — you have 180 days from the denial to file. The plan must decide within 30 days (before service) or 60 days (after service); 72 hours if urgent.
External review — available for at least 4 months after the final internal denial, for medical-necessity and "experimental" denials (PGT-A, ICSI, step therapy). An independent reviewer decides within 45 days. Contractual exclusions are not eligible for external review — those go to the regulator as a complaint.
Regulator — Vermont Department of Financial Regulation, Insurance Division. Vermont independent external review of health care service decisions (Code Vt. R. 21-040-012, revised eff. 2023-05-02) File a complaint. Copy the regulator on every appeal letter; clinics report it speeds things up.
If your plan is self-funded, skip the state regulator: your appeal runs under ERISA and complaints go to the U.S. Department of Labor's Employee Benefits Security Administration.
Common denial reasons and what to argue
Step therapy / prior-treatment requirements — check your plan's own Summary Plan Description or clinical policy for its step-therapy criteria and ask the payer for its bypass criteria (age 38+, tubal factor, stage III–IV endometriosis, severe male factor are common).
Benefit limits — if your employer voluntarily covers fertility care, the denial is governed entirely by the plan document, not state law; ask for the exact clause the denial relied on.
'Experimental' (PGT-A, ERA, ICSI without male factor) — eligible for external review; ask the clinic for a medical-necessity letter. Success is limited for PGT-A.
Medication routing — many denials are the wrong pharmacy or a missing prior auth, not a coverage decision. Ask the specialty pharmacy to re-run with prior auth.
AI-only review — several states now bar insurers from denying on medical necessity without a physician's individualized review; ask in writing whether AI was the sole basis.
Free, 5 steps, nothing saved unless you choose to.
Where people get surprised
Nothing is required of any Vermont plan today — fully insured, self-funded, or individual-market.
H.302 (2025-2026 biennium) would have required health insurers and Vermont Medicaid to cover fertility diagnosis, IVF (including genetic testing as part of IVF), clinically appropriate fertility medications, and fertility preservation, with insurance provisions proposed to take effect for plans issued on or after 2026-01-01 (no later than 2027-01-01) — it died in the House Health Care Committee, marked 'Dead' as of 2026-05-29, without passing either chamber.
H.55 (2025-2026 biennium), an earlier, narrower companion bill covering fertility treatment alongside gender-affirming care, also died in the House Health Care Committee without a committee vote.
Vermont Medicaid does not currently cover IVF or infertility treatment. H.302 would have directed the Agency of Human Services to seek CMS approval (by 2025-09-01) for a Medicaid fertility benefit, but that request is moot now that the bill is dead.
What may change
VT H.302 (2025-2026) — Would have required Vermont health insurers and Medicaid to cover fertility diagnosis, IVF (genetic testing as part of IVF, clinically appropriate fertility-related medications, and fertility preservation services), and prohibited discriminatory financial limits based on donor-gamete or surrogacy use. Insurance provisions proposed effective for plans issued on or after 2026-01-01, no later than 2027-01-01; Medicaid provisions were contingent on a CMS state plan amendment the Agency of Human Services was directed to request by 2025-09-01. Status: Introduced 2025 session (VT LEG #380804); referred to the House Committee on Health Care; never received a committee vote; status changed to 'Dead' 2026-05-29..
VT H.55 (2025-2026) — Companion/earlier bill relating to coverage for fertility treatment and gender-affirming health care services (VT LEG #379409). Status: Introduced 2025-01-22; referred to the House Committee on Health Care; died in committee without a vote (25% progression)..
This page explains public coverage rules and typical prices as of the dates shown. It is an estimate and an interpretation, not a coverage decision by your plan, and not legal, medical, tax, or insurance advice. Your plan documents control. We never store what you enter here unless you choose to save a plan.